Obesity CRO Services

Empowering advancements in obesity treatment through expert trial management and patient-centered care.

Business worker collaborating around a blackboard

Advancing Obesity Treatments with Expert Support

The obesity drug market is experiencing unprecedented growth, driven by the success of groundbreaking treatments. As more pharmaceutical companies, especially smaller and mid-sized firms, seek to contribute to this dynamic field, the need for expertly managed clinical trials has never been more critical. ProPharma offers specialized services to help you navigate the complexities of obesity clinical trials, ensuring your study not only advances scientific understanding but also brings effective treatments to patients who need them.

Submissions icon

Navigating the Challenges of Rapid Enrollment

Navigating the Challenges of Rapid Enrollment

Authority Meetings icon

Addressing Patient Dropout with Proven Strategies

Addressing Patient Dropout with Proven Strategies

Patient support programs icon

Designing Trials That Reduce Patient Burden

Designing Trials That Reduce Patient Burden

Pin leading to another pin icon

Comprehensive Support from Start to Finish

Comprehensive Support from Start to Finish

Research platforms icon

Data Visualization

Data Visualization

Navigating the Challenges of Rapid Enrollment

One of the primary challenges in obesity clinical trials is the speed at which enrollment can occur. Rapid enrollment is a double-edged sword; while it can accelerate your timeline, it also requires a robust monitoring strategy to maintain the integrity of your data. ProPharma's experienced team ensures your trial is equipped with a proactive monitoring approach that adapts to fast-paced enrollments, minimizing risks and maintaining the highest quality standards.

Healthcare provider writing on clipboard

Addressing Patient Dropout with Proven Strategies

In obesity trials, patient dropout can be a significant issue, particularly when participants suspect they are on a placebo. Our team understands the importance of keeping patients engaged throughout the study. We employ evidence-based strategies to minimize dropout rates, including enhanced patient communication, regular check-ins, and innovative patient engagement tools. Our goal is to keep your trial on track, supporting both patients and sponsors by maintaining study continuity and reducing time and cost implications.

Healthcare professionals in lab coats conversing around a table

Designing Trials That Reduce Patient Burden

Patient burden is a key factor in both compliance and retention in clinical trials for obesity. ProPharma is committed to designing and executing trials that consider the patient experience at every step. We implement patient-centric trial designs that reduce the burden on participants, whether through simplified protocols, decentralized trials, or flexible scheduling. By focusing on patient needs, we help you achieve higher retention rates and more reliable data, ultimately contributing to better treatment outcomes.

Two lab techs working with petri dishes test tubs in clean room

Comprehensive Support from Start to Finish

ProPharma offers end-to-end support for your obesity clinical trials, from study design to regulatory submissions. Our expertise spans the full spectrum of trial management, including site selection, patient recruitment, data management, and regulatory compliance. With our global reach and deep therapeutic expertise, we are well-positioned to support your trial's success, no matter its size or complexity.

Business worker sharing papers around a conference table

Data Visualization

Our clients are able to easily digest their fast enrolling data with our unique data visualization tool.

Obesity CRO data visualization tool screenshot

Accelerate Obesity & Diabetes Clinical Trials

ProPharma has the expertise to accelerate obesity clinical trials by offering comprehensive regulatory support and biostatistical expertise in trial design. In a competitive landscape where many seek obesity drug approvals, our ability to expedite the process is a key differentiator. Additionally, we provide in-house medical and regulatory expertise to efficiently manage and execute these trials, helping you bring your drug to market faster.

Decentralized Clinical Trials

ProPharma’s decentralized clinical trials (DCTs) offer a flexible approach to executing trials more broadly, allowing sponsors to reach diverse populations and patients who may not have access to traditional trial sites. By utilizing virtual, remote, or hybrid models, ProPharma facilitates easier participation while maintaining regulatory compliance and data integrity. This approach reduces geographic barriers, accelerates patient recruitment, and enhances engagement, leading to more efficient and inclusive trial execution that ultimately improves trial outcomes.

Health care worker with a patient in a home

Why Choose ProPharma?

Full Service Clinical Trials icon

Proven Experience

Decades of experience managing obesity clinical trials across diverse populations.

Caregiver person holding child icon

Patient-Centric Approach

Focused on minimizing patient burden to improve retention and data quality.

Innovation icon

Innovative Strategies

Cutting-edge monitoring and engagement strategies to manage rapid enrollment and minimize dropout rates.

Global submission icon

Global Reach

A worldwide network of sites and regulatory expertise to support your trial across multiple regions.

Ready to Partner with ProPharma?

If you’re committed to advancing innovative obesity treatments and want a partner who understands the unique challenges of obesity clinical trials, ProPharma is here to support your journey. Contact our team today to discover how we can help you bring effective solutions to market.

News & Insights

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

PMA Post-Approval Study Considerations

October 7, 2024

PMA Post-Approval Study Considerations

Learn the essential considerations for conducting Post-Approval Studies (PAS) for medical devices, including protocols, timelines, and reporting requirements to ensure compliance with FDA regulations.

What is a Clinical Evaluation Report (CER)?

September 30, 2024

What is a Clinical Evaluation Report (CER)?

Learn the fundamentals of a Clinical Evaluation Report (CER), its evolution under EU MDR, and strategies for ensuring compliance with medical device regulations.

ProPharma Names Dawn Sherman Chief Executive Officer

September 30, 2024

ProPharma Names Dawn Sherman Chief Executive Officer

Dawn Sherman rejoins ProPharma as CEO, bringing nearly 30 years of industry experience to lead the regulatory, clinical, and compliance services provider.

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

ProPharma Receives 2024 CRO Leadership Award

June 13, 2024

ProPharma Receives 2024 CRO Leadership Award

ProPharma wins 2024 CRO Leadership Award for exceeding expectations in key categories, solidifying its position as a top global research consulting organization in the life sciences industry.

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

ProPharma Receives 2024 CRO Leadership Award

June 13, 2024

ProPharma Receives 2024 CRO Leadership Award

ProPharma wins 2024 CRO Leadership Award for exceeding expectations in key categories, solidifying its position as a top global research consulting organization in the life sciences industry.

EY Announces Michael Stomberg as an Entrepreneur Of the Year® 2023 National Finalist

November 27, 2023

EY Announces Michael Stomberg as an Entrepreneur Of the Year® 2023 National Finalist

Ernst & Young announces Michael Stomberg as a finalized for Entrepreneur Of The Year® 2023 National Award to celebrate ambitious entrepreneurs.

Infographic The Cost of Poor Project Management - ProPharma

June 10, 2022

The Cost of Poor Project Management

Project Management isn’t for the faint of heart. There is a shockingly high rate of project failure… but on the other hand, great project management can be a key differentiator that leads a company...

Infographic Successfully Passing MHRA Inspections for Overseas Manufacturing Sites - ProPharma

August 31, 2022

Successfully Passing MHRA Inspections for Overseas Manufacturing Sites

ProPharma offers GMP and GDP compliance services from clinical development to commercial distribution of the products' lifecycle. ProPharma’s Compliance and Quality team completed the first on-site...

Infographic Navigating the Generic Drug Application and Approval Process - ProPharma

October 4, 2021

Navigating the Generic Drug Application and Approval Process

Navigating the generic drug application and approval process can be challenging. From pre-filing through post-approval, find out exactly what needs to be done for your Abbreviated New Drug...

News & Insights

ProPharma Names Dawn Sherman Chief Executive Officer

September 30, 2024

ProPharma Names Dawn Sherman Chief Executive Officer

Dawn Sherman rejoins ProPharma as CEO, bringing nearly 30 years of industry experience to lead the regulatory, clinical, and compliance services provider.

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

ProPharma Receives 2024 CRO Leadership Award

June 13, 2024

ProPharma Receives 2024 CRO Leadership Award

ProPharma wins 2024 CRO Leadership Award for exceeding expectations in key categories, solidifying its position as a top global research consulting organization in the life sciences industry.

Previous Post Arrow Next Post Arrow
ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

ProPharma Receives 2024 CRO Leadership Award

June 13, 2024

ProPharma Receives 2024 CRO Leadership Award

ProPharma wins 2024 CRO Leadership Award for exceeding expectations in key categories, solidifying its position as a top global research consulting organization in the life sciences industry.

EY Announces Michael Stomberg as an Entrepreneur Of the Year® 2023 National Finalist

November 27, 2023

EY Announces Michael Stomberg as an Entrepreneur Of the Year® 2023 National Finalist

Ernst & Young announces Michael Stomberg as a finalized for Entrepreneur Of The Year® 2023 National Award to celebrate ambitious entrepreneurs.

Previous Award Arrow Next Award Arrow
ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

PMA Post-Approval Study Considerations

October 7, 2024

PMA Post-Approval Study Considerations

Learn the essential considerations for conducting Post-Approval Studies (PAS) for medical devices, including protocols, timelines, and reporting requirements to ensure compliance with FDA regulations.

What is a Clinical Evaluation Report (CER)?

September 30, 2024

What is a Clinical Evaluation Report (CER)?

Learn the fundamentals of a Clinical Evaluation Report (CER), its evolution under EU MDR, and strategies for ensuring compliance with medical device regulations.

Previous Post Arrow Next Post Arrow
Infographic The Cost of Poor Project Management - ProPharma

June 10, 2022

The Cost of Poor Project Management

Project Management isn’t for the faint of heart. There is a shockingly high rate of project failure… but on the other hand, great project management can be a key differentiator that leads a company...

Infographic Successfully Passing MHRA Inspections for Overseas Manufacturing Sites - ProPharma

August 31, 2022

Successfully Passing MHRA Inspections for Overseas Manufacturing Sites

ProPharma offers GMP and GDP compliance services from clinical development to commercial distribution of the products' lifecycle. ProPharma’s Compliance and Quality team completed the first on-site...

Infographic Navigating the Generic Drug Application and Approval Process - ProPharma

October 4, 2021

Navigating the Generic Drug Application and Approval Process

Navigating the generic drug application and approval process can be challenging. From pre-filing through post-approval, find out exactly what needs to be done for your Abbreviated New Drug...

Previous Resource Arrow Next Resource Arrow